Literature DB >> 21085190

Vitiligo autoantigen VIT75 is identified as lamin A in vitiligo by serological proteome analysis based on mass spectrometry.

Qiang Li1, Yajie Lv, Chunying Li, Xiuli Yi, Heather A Long, Hongjiang Qiao, Tao Lu, Qi Luan, Kai Li, Xudong Wang, Gang Wang, Tianwen Gao.   

Abstract

VIT75 is a 75-kDa melanocyte membrane antigen (Ag) that had been observed, but not identified until now. Its immunopathogenic role in vitiligo remains unknown. In this study, serological proteome analysis based on mass spectrometry was employed to identify VIT75. Three disparate 75-, 60-, and 45-kDa proteins on two-dimensional (2D) gel were, respectively, identified as lamin A, tyrosinase-related protein 1, and melanin-concentrating hormone receptor 1. The latter two proteins are well-known Ags. Immunoreactivity analysis showed that the 75-kDa protein displayed on the 2D gel was recognized by human anti-lamin A IgG. Antibody (Ab) reactivity to lamin A was positive in 28.6% of patients' sera. Only 3.1% healthy sera reacted with the lamin A. A total of 91.7% of the positive sera was from the active non-segmental vitiligo (NSV). The positive rate and mean titer of anti-lamin A Ab are higher for NSV with autoimmune disease than for NSV without autoimmune disease. These data demonstrate that VIT75 is lamin A. To our knowledge, this is a previously unreported vitiligo Ag. Anti-lamin A Ab may be a potential marker of NSV with autoimmune disease. The study indicates that the targets of autoantibodies in vitiligo patients can be revealed by serological proteome analysis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21085190     DOI: 10.1038/jid.2010.341

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

1.  Nonsegmental vitiligo and autoimmune mechanism.

Authors:  Naoki Oiso; Tamio Suzuki; Kazuyoshi Fukai; Ichiro Katayama; Akira Kawada
Journal:  Dermatol Res Pract       Date:  2011-07-26

2.  An Optimized Fluorescence-Based Bidimensional Immunoproteomic Approach for Accurate Screening of Autoantibodies.

Authors:  Virginie Dutoit-Lefèvre; Sylvain Dubucquoi; David Launay; Vincent Sobanski; Patricia Dussart; Philippe Chafey; Cédric Broussard; Sophie Duban-Deweer; Patrick Vermersch; Lionel Prin; Didier Lefranc
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

Review 3.  Coherent somatic mutation in autoimmune disease.

Authors:  Kenneth Andrew Ross
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

4.  Identification of the Risk HLA-A Alleles and Autoantigen in Han Chinese Vitiligo Patients and the Association of CD8+T Cell Reactivity with Disease Characteristics.

Authors:  Xiuli Yi; Tingting Cui; Shuli Li; Yuqi Yang; Jiaxi Chen; Sen Guo; Zhe Jian; Chunying Li; Tianwen Gao; Ling Liu; Kai Li
Journal:  Med Sci Monit       Date:  2018-09-16

5.  The Formation of Melanocyte Apoptotic Bodies in Vitiligo and the Relocation of Vitiligo Autoantigens under Oxidative Stress.

Authors:  Jun Tian; Yaojun Wang; Ming Ding; Yue Zhang; Jiaoni Chi; Tao Wang; Bin Jiao; Zhe Jian; Xiuli Yi; Ye Huang; Ling Liu; Kai Li; Jiaxi Chen; Gang Wang; Tianwen Gao; Chunying Li; Qiang Li
Journal:  Oxid Med Cell Longev       Date:  2021-10-28       Impact factor: 6.543

6.  Identification of Novel HLA-A*0201-Restricted CTL Epitopes in Chinese Vitiligo Patients.

Authors:  Tingting Cui; Xiuli Yi; Sen Guo; Fubo Zhou; Ling Liu; Chunying Li; Kai Li; Tianwen Gao
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.